China Sunergy Co., Ltd. (NASDAQ:CSUN), a specialized solar cell and module manufacturer, announced that the Company has signed a share transfer agreement with its affiliated company, China Electric Equipment Group Co., Ltd. (“CEEG”), under which the Company agreed to sell and CEEG agreed to purchase, 100% of the equity interest in China Sunergy (Shanghai) Co., Ltd. (“Sunergy Shanghai”), a subsidiary of the Company, for a total consideration of approximately RMB 231.2 million (US$37.7 million) (the “Total Consideration”) (the “Transaction”). China Sunergy Co Ltd (NASDAQ:CSUN) shares after opening at $4.20 moved to $4.45 on last trade day and at the end of the day closed at $4.19. Company price to sales ratio in past twelve months was calculated as 0.25 and price to cash ratio as 1.97. China Sunergy Co Ltd (NASDAQ:CSUN) showed a negative weekly performance of -18.16%.
Cytokinetics, Inc. (NASDAQ:CYTK) is poised to benefit from a milestone payment from Astellas Pharma Inc as it brings its skeleton muscles activator drug CK-2127107 to the next level of Phase I trial. The company announced that it is launching what is known as placebo-controlled, randomized and double-blind clinical study of the drug. The study has been dubbed CY5012. Thus, in the CY5012, the company will be seeking to get to the bottom of the drug’s tolerability and safety among other issues related to drug’s dosage and usage. As this happens, Cytokinetics, Inc. (NASDAQ:CYTK) prepared to receive $2 million in milestone payment under its collaboration terms with Astellas Pharma Inc. The two companies entered collaboration agreement in June 2013. Cytokinetics, Inc. (NASDAQ:CYTK) shares fell -4.16% in last trading session and ended the day on $8.98. CYTK return on equity ratio is recorded as -65.90% and its return on assets is -40.80%. Cytokinetics, Inc. (NASDAQ:CYTK) yearly performance is 31.29%.
During the fourth quarter, BlackBerry Ltd (NASDAQ:BBRY) said hardware accounts 37% of its revenue on approximately 1.3 million BlackBerry smartphones. Services accounts 56% and software and other areas represent 7% of its revenue. BlackBerry Ltd (NASDAQ:BBRY) shares moved down -7.07% in last trading session and was closed at $8.41, while trading in range of $8.21-$9.64. BlackBerry Ltd (NASDAQ:BBRY) year to date performance is 13.04%.
Finish Line Inc (NASDAQ:FINL) reported its fourth quarter fiscal 2014 earnings and full fiscal year earnings before the opening bell. On the results, Chairman and CEO Glenn S. Lyon commented: “Our strong fourth quarter performance represented a great finish to a transformative year. Finish Line Inc (NASDAQ:FINL) weekly performance is -3.77%. On last trading day company shares ended up $27.05. Finish Line Inc (NASDAQ:FINL) distance from 50-day simple moving average is 2.96%. Analysts mean target price for the company is $29.81.